-
MFGE8–ANXA1–SMAD2/3 in Pancreatic Fibrosis
2026-08-28
This study presents a multimodal strategy for chronic pancreatitis that combines umbilical cord-derived mesenchymal stem cells, their extracellular vesicles, and recombinant MFGE8 nanoparticles. Its central contribution is the identification of an MFGE8-dependent ANXA1–SMAD2/3 mechanism that links extracellular-vesicle activity to reduced pancreatic stellate-cell fibrosis and improved disease features in mice.
-
SIX1 Drives De Novo Lipogenesis in Liver Cancer
2026-08-28
The reference study identifies SIX1 as a direct transcriptional driver of de novo lipogenesis in liver cancer cells, linking ACLY, FASN, and SCD1 expression to AIB1 and HBO1/KAT7-dependent chromatin regulation. It also defines an insulin-responsive DGUOK-AS1–miR-145-5p–SIX1 axis that connects lipid synthesis with tumor proliferation, invasion, metastasis, and patient prognosis.
-
PRINT: RNA-Mediated Transgene Insertion at Safe Harbors
2026-08-27
Zhang and colleagues introduce PRINT, an RNA-only strategy that repurposes avian R2 retroelement proteins for site-specific transgene insertion at a multicopy human safe-harbor locus. The study combines target-primed reverse transcription with two in vitro transcribed RNAs and reports efficient, substantially full-length insertion in cultured human primary cells without a DNA donor.
-
Tranexamic Acid in Fibrinolysis Research
2026-08-27
Tranexamic Acid connects plasmin biology to practical clot-stability assays and next-generation wound-dressing models. This guide covers concentration planning, assay controls, formulation translation, and troubleshooting for reproducible inhibition of fibrinolysis.
-
Novobiocin Workflows for Antimicrobial Research
2026-08-26
Novobiocin is an aminocoumarin antibiotic that supports comparative bacterial susceptibility testing as well as antiparasitic, antiviral, and host-protein studies. This practical guide converts published staphylococcal findings into reproducible bench workflows, decision points, and troubleshooting strategies.
-
LRG1 and Neutrophil Mitochondria in Bladder Cancer
2026-08-26
This 2026 Advanced Science study identifies a tumor-derived LRG1–ANXA2 interaction that disrupts neutrophil mitochondrial homeostasis, promotes mtROS-dependent NETosis, and destabilizes bladder cancer vasculature. Its findings connect mitochondrial dysfunction with vascular pathology and therapeutic resistance, while suggesting that blocking the LRG1–NETosis axis could improve cisplatin delivery and anti-PD-1 responses.
-
Doxorubicin as a Senescence-Mechanism Probe
2026-08-25
Doxorubicin, also known as Adriamycin, is more than a cytotoxic control: it can help researchers distinguish DNA-damage-driven killing from senescence-associated phenotypes. This guide translates a recent Lactobacillus plantarum nanovesicle study into state-resolved assay design and interpretation.
-
Sex Differences in Angiotensin II Hypertension
2026-08-25
Xue, Pamidimukkala, and Hay used telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II causes substantially greater hypertension in male than female conscious mice. The findings link sex-dependent blood-pressure responses to hormonal modulation, baroreflex resetting, and sympathetic maintenance of arterial pressure, offering a rigorous framework for sex-informed cardiovascular research.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-08-24
This scenario-driven guide explains how Cy3 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1207, can improve secondary-antibody detection in cell viability, proliferation, cytotoxicity, immunofluorescence, and flow cytometry workflows. It emphasizes controls, compatibility, titration, storage, and interpretation so fluorescent signal is not mistaken for a direct measure of cell health.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA) Workflows
2026-08-24
Build reproducible ERK/MAPK pathway activation experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from PKC assays to neuronal injury and skin cancer models. The workflow emphasizes time-resolved phospho-ERK measurement, mitochondrial and autophagy readouts, and practical controls that distinguish pathway activation from nonspecific toxicity.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-08-23
This guide explains how to prepare, store, control, and interpret (+)-Bicuculline for experiments requiring competitive GABAA receptor antagonism. It is a neuroscience research tool for controlled in vitro or model-specific in vivo work, not a diagnostic, clinical, or therapeutic product.
-
Substance P: Mechanism, Evidence, and Workflow
2026-08-22
Substance P is an undecapeptide tachykinin neuropeptide that signals primarily through the neurokinin-1 receptor. This article connects its roles in pain transmission research, inflammation, and immune response modulation with evidence-based handling guidance for the B6620 research product.
-
MFGE8 Nanomedicine for Pancreatic Fibrosis
2026-08-22
This study identifies a paracrine antifibrotic mechanism in which umbilical cord mesenchymal stem cell extracellular vesicles deliver MFGE8 to regulate the ANXA1–SMAD2/3 axis in pancreatic stellate cells. It also translates this mechanism into a recombinant MFGE8 nanoparticle platform, linking cell-based therapy, extracellular vesicles, and nanomedicine in chronic pancreatitis models.
-
Cy3 TSA Fluorescence System Kit for Spatial Biology
2026-08-21
The Cy3 TSA Fluorescence System Kit connects ultrasensitive fluorescence microscopy detection with modern spatial-biology questions. This article explains how tyramide deposition, tissue heterogeneity, and proximity-proteomics insights can guide more defensible IHC, ICC, and ISH assay design.
-
L-NMMA acetate: NOS Pathway Research Workflows
2026-08-20
L-NMMA acetate provides a practical way to test whether nitric oxide signaling drives osteogenic, inflammatory, or vascular phenotypes. This guide translates dental follicle cell findings into controlled dose-response workflows, pathway readouts, and troubleshooting decisions.